Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Sep-23 4:49 PM View:  | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 18-Sep-23 | Purchase | 751,233 | $9.24 | $6,944,920.00 | < 1% 137.43M to 138.18M | |
| 19-Sep-23 4:49 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 15-Sep-23 | Purchase | 1,401,500 | $9.05 | $12,680,700.00 | 1% 136.03M to 137.43M | |
| 09-Jun-23 4:17 PM View: | Glover Steve C Director | Ambrx Biopharma Inc. (AMAM) | 07-Jun-23 | Grant | 85,000 | -- | -- | 100% 0 to 85.0K | |
| 09-Jun-23 4:05 PM View: | Loesberg Janet Director | Ambrx Biopharma Inc. (AMAM) | 07-Jun-23 | Grant | 85,000 | -- | -- | 100% 0 to 85.0K | |
| 09-Jun-23 4:05 PM View: | Maier Paul V Director | Ambrx Biopharma Inc. (AMAM) | 07-Jun-23 | Grant | 85,000 | -- | -- | 100% 0 to 85.0K | |
| 09-Jun-23 10:00 PM View: | Hermans Kate Director | Ambrx Biopharma Inc. (AMAM) | 07-Jun-23 | Grant | 85,000 | -- | -- | 100% 0 to 85.0K | |
| 28-Apr-23 5:59 PM View: | O'Connor Daniel President and CEO Director | Ambrx Biopharma Inc. (AMAM) | 26-Apr-23 | Grant | 2,750,000 | -- | -- | 100% 0 to 2.75M | |
| 28-Apr-23 6:00 PM View: | Nelson Sonja Chief Fin. & Operating Officer | Ambrx Biopharma Inc. (AMAM) | 26-Apr-23 | Grant | 1,000,000 | -- | -- | 100% 0 to 1000.0K | |
| 20-Apr-23 6:04 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 20-Apr-23 | Purchase | 886,634 | $11.60 | $10,285,200.00 | < 1% 198.33M to 199.21M | |
| 20-Apr-23 6:04 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 19-Apr-23 | Purchase | 951,909 | $11.15 | $10,612,400.00 | < 1% 197.38M to 198.33M | |
| 20-Apr-23 6:04 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 18-Apr-23 | Purchase | 3,376,650 | $11.27 | $38,053,100.00 | 2% 194.0M to 197.38M | |
| 17-Apr-23 5:46 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 17-Apr-23 | Purchase | 562,121 | $10.67 | $5,999,460.00 | < 1% 183.76M to 184.33M | |
| 17-Apr-23 5:46 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 14-Apr-23 | Purchase | 841,967 | $9.96 | $8,384,310.00 | < 1% 182.92M to 183.76M | |
| 17-Apr-23 5:46 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 13-Apr-23 | Purchase | 1,193,810 | $9.16 | $10,935,500.00 | < 1% 181.73M to 182.92M | |
| 16-Mar-23 10:00 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 16-Mar-23 | Purchase | 500,000 | $10.15 | $5,074,250.00 | < 1% 158.75M to 159.25M | |
| 16-Mar-23 10:00 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 15-Mar-23 | Purchase | 250,000 | $10.60 | $2,648,880.00 | < 1% 158.5M to 158.75M | |
| 16-Mar-23 10:00 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma Inc. (AMAM) | 14-Mar-23 | Purchase | 250,000 | $9.95 | $2,488,280.00 | < 1% 158.25M to 158.5M |
